Reuters: Health
Swiss drugmakers Roche and Novartis underscored how their portfolios are increasingly clashing on the commercial battlefield, announcing on Wednesday new data on drugs aimed at capturing market share from each other.
Subscribe UsPopular Posts
|
No comments:
Post a Comment